CJC No DAC 5mg + Ipamorelin 5mg

CJC No DAC + Ipamorelin combines two research peptides frequently studied together for their activity involving growth hormone signaling and secretion pathways.

CJC No DAC is a short-acting growth hormone–releasing hormone (GHRH) analog studied for its interaction with the pituitary gland and its potential influence on pulsatile growth hormone release.

Ipamorelin is a selective growth hormone secretagogue studied for its activity at the ghrelin (GHS-R1a) receptor and its role in stimulating growth hormone release.

Because these compounds act through different signaling pathways, the combination is commonly investigated in research examining growth hormone dynamics, endocrine signaling, recovery-related pathways, body composition, and metabolic processes.

Product Details

• CJC No DAC: 5mg

• Ipamorelin: 5mg

• Total peptide content: 10mg

• Form: Lyophilized powder

• Laboratory research product

Research Areas

CJC No DAC + Ipamorelin has been investigated in research related to:

• Growth hormone signaling

• Pulsatile GH secretion

• IGF-1 pathways

• Metabolic signaling

• Body-composition pathways

• Recovery and tissue-related signaling

Research Use Only

This product is intended strictly for laboratory and research purposes. It is not intended for human or veterinary use, consumption, diagnosis, treatment, cure, or prevention of any disease. Statements regarding this product have not been evaluated by the FDA.